Analysis of Modifiers of Mammary Tumor Susceptibility

描述（由申请人提供）：癌症是一种多基因疾病，涉及许多基因产物和许多细胞类型的相互作用。虽然人们把注意力集中在对肿瘤发展过程有很大影响的单个基因的鉴定上，但很明显，没有一个单一的遗传变化足以使正常细胞变成恶性细胞。虽然肿瘤细胞中存在多种遗传变化，但肿瘤发展的一个方面是在癌症发展中未突变的基因的功能中自然变异的作用。确定这些“修饰基因”或“易感基因”的功能对于理解肿瘤发展过程至关重要。小鼠是进行这类研究的极好模型。携带ApcMin等位基因的小鼠易发生乳腺增生和肿瘤。遗传背景影响这些小鼠乳腺中的病变类型、病变数量和肿瘤潜伏期。B6 ApcMin/+小鼠在暴露于致癌物后迅速发生乳腺鳞状细胞癌。FVBxB 6 ApcMin/+小鼠在相同处理后主要发生肺泡增生和癌，但很少发生。为了鉴定导致这种表型差异的基因，进行了回交分析，并鉴定了几个修饰基因座。该项目的目标是1）产生同类FVB ApcMin/+小鼠，以便更完整地表征遗传背景的影响; 2）产生并表征携带FVB或修饰物之一Mmom 2的129等位基因的小鼠的同类系;和3）将Mmom 2定位到足够小的间隔，以允许基因座的遗传鉴定; 4）进一步表征由Mmom 2赋予的分子表型;和5）使用基因表达的变化来鉴定受Mmom 2影响的分子途径。这些研究的最终目标是鉴定编码Mmom 2的基因，并了解其对肿瘤发展的影响。了解这种基因产物如何改变启动细胞的命运，将为被诊断患有乳腺癌前病变的女性制定靶向治疗和治疗策略提供信息。公共卫生相关性：乳腺癌显示出强烈的家族倾向，但大多数病例不能归因于主基因的影响。因此，大多数乳腺癌的病例将是由于基因的影响的总和较小，但显着的影响。本项目的目标是使用小鼠模型来识别和表征这样一个位点的功能。

DESCRIPTION (provided by applicant): Cancer is a multigenic disease that involves the interplay of many gene products and many cell types. While much concentration has been placed on the identification of single genes that have a large effect on the process of tumor development, it is clear that no one single genetic change is sufficient for a normal cell to become malignant. While multiple genetic changes are present in tumor cells, one aspect of tumor development is the role of natural variation in the function of genes that are not mutated in cancer development. Determining the function of these "modifier" or "susceptibility" genes is vital to understanding the process of tumor development. Mice are excellent models with which to perform this type of study. Mice carrying the ApcMin allele are predisposed to develop mammary hyperplasias and tumors. Genetic background affects the type of lesion, the number of lesions, and tumor latency in the mammary glands of these mice. B6 ApcMin/+ mice rapidly develop squamous cell carcinomas of the mammary gland after exposure to a carcinogen. FVBxB6 ApcMin/+ mice develop mainly alveolar hyperplasias and carcinomas only rarely after the same treatment. To identify the genes responsible for this phenotypic difference, a backcross analysis was performed and several modifier loci have been identified. The goals of this project are to 1) generate congenic FVB ApcMin/+ mice in order to characterize the effect of the genetic background more completely; 2) generate and characterize congenic lines of mice that carry either the FVB or 129 allele of one of the modifiers, Mmom2; and 3) to map Mmom2 to a interval small enough to allow genetic identification of the loci;4) to further characterize the molecular phenotype conferred by Mmom2; and 5) to use changes in gene expression to identify molecular pathways affected by Mmom2. The ultimate goals of these studies are to identify the gene encoding Mmom2 and understand the effect on tumor development. Understanding how this gene product can alter the fate of initiated cells will inform the development of targeted treatments and treatment strategies for women who have been diagnosed with preneoplastic lesions in the breast. PUBLIC HEALTH RELEVANCE: Breast cancer shows a strong familial tendency, but most cases cannot be ascribed to the effect of major genes. Thus, most cases of breast cancer will be due to the sum of the effects of genes with smaller, though significant effects. The goal of this project is to identify and characterize the function of one such locus using a mouse model.